[go: up one dir, main page]

BR0312305A - Sistema contendo vitaminas para estabilizar a resposta imune externa e interna de animais - Google Patents

Sistema contendo vitaminas para estabilizar a resposta imune externa e interna de animais

Info

Publication number
BR0312305A
BR0312305A BR0312305-7A BR0312305A BR0312305A BR 0312305 A BR0312305 A BR 0312305A BR 0312305 A BR0312305 A BR 0312305A BR 0312305 A BR0312305 A BR 0312305A
Authority
BR
Brazil
Prior art keywords
animals
vitamin
immune response
stabilize
external
Prior art date
Application number
BR0312305-7A
Other languages
English (en)
Inventor
John Erik Hansen
Original Assignee
John Erik Hansen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Erik Hansen filed Critical John Erik Hansen
Publication of BR0312305A publication Critical patent/BR0312305A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SISTEMA CONTENDO VITAMINAS PARA ESTABILIZAR A RESPOSTA IMUNE EXTERNA E INTERNA DE ANIMAIS". Um sistema contendo vitaminas para estabilizar a resposta imune de animais consiste em duas partes ou 'kits' que podem ser usadas sucessivamente ou separadamente, uma incluindo principalmente biotina e outra incluindo principalmente vitaminas E e C. Ambos os kits incluindo alicina e rabanetes esmagados e são misturados em um veículo. O sistema é usado para o tratamento de várias doenças em animais, especialmente em rebanhos.
BR0312305-7A 2002-07-02 2003-07-02 Sistema contendo vitaminas para estabilizar a resposta imune externa e interna de animais BR0312305A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02388044A EP1378177A1 (en) 2002-07-02 2002-07-02 Vitamin-containing system for stabilising the immune response of animals
PCT/DK2003/000462 WO2004004483A1 (en) 2002-07-02 2003-07-02 Vitamin-containing system for stabilising the immune response of animals

Publications (1)

Publication Number Publication Date
BR0312305A true BR0312305A (pt) 2005-04-12

Family

ID=29719801

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312305-7A BR0312305A (pt) 2002-07-02 2003-07-02 Sistema contendo vitaminas para estabilizar a resposta imune externa e interna de animais

Country Status (9)

Country Link
US (1) US20060034957A1 (pt)
EP (1) EP1378177A1 (pt)
JP (1) JP2005531318A (pt)
CN (1) CN1665401A (pt)
AU (1) AU2003236823A1 (pt)
BR (1) BR0312305A (pt)
CA (1) CA2490952A1 (pt)
PL (1) PL374885A1 (pt)
WO (1) WO2004004483A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11220545B2 (en) 2014-12-08 2022-01-11 Dana-Farber Cancer Institute, Inc. Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents
US11207393B2 (en) 2015-10-16 2021-12-28 President And Fellows Of Harvard College Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
CA3018332A1 (en) 2016-03-21 2017-09-28 Dana-Farber Cancer Institute, Inc. T-cell exhaustion state-specific gene expression regulators and uses thereof
US20210032334A1 (en) 2018-02-28 2021-02-04 Dana-Farber Cancer Institute, Inc. Methods for treating cancer using combinations of anti-btnl2 and immune checkpoint blockade agents
US12103972B2 (en) 2018-04-06 2024-10-01 Dana-Farber Cancer Institute, Inc. KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof
JP2022513082A (ja) 2018-11-19 2022-02-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 免疫応答を調節するためのＩＲＥ１α－ＸＢＰ１シグナル伝達経路バイオマーカーの使用
US20220289854A1 (en) 2019-04-30 2022-09-15 Dana-Farber Cancer Institute, Inc. Methods for treating cancer using combinations of anti-cx3cr1 and immune checkpoint blockade agents
US20230075965A1 (en) 2020-01-24 2023-03-09 Constantine S. Mitsiades Uses of biomarkers for improving immunotherapy
WO2022159575A1 (en) 2021-01-20 2022-07-28 Bioentre Llc Ctla4-binding proteins and methods of treating cancer
US20240280561A1 (en) 2021-06-08 2024-08-22 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
WO2023240287A1 (en) 2022-06-10 2023-12-14 Bioentre Llc Combinations of ctla4 binding proteins and methods of treating cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
AT405477B (de) * 1996-04-03 1999-08-25 Norbert Mag Fuchs Kombinationspräparat
CN1275914A (zh) * 1996-09-27 2000-12-06 刈田毅 以除去自由基为目的的抗氧化组合物、含有该组合物的药物组合物及其制造方法
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
DE19858670C2 (de) * 1998-12-18 2001-07-12 Heinz Kasik Mittel zur Pflege von Haut, Nägeln und Haaren und zur Förderung des Haarwachstums
DE19907586A1 (de) * 1999-02-22 2000-08-24 Bonermo Health Gmbh Zirkadian angepaßte Produkte zur Nahrungsergänzung

Also Published As

Publication number Publication date
EP1378177A1 (en) 2004-01-07
AU2003236823A1 (en) 2004-01-23
PL374885A1 (en) 2005-11-14
JP2005531318A (ja) 2005-10-20
US20060034957A1 (en) 2006-02-16
WO2004004483A1 (en) 2004-01-15
CN1665401A (zh) 2005-09-07
CA2490952A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
Jiang et al. Dietary plasma protein is used more efficiently than extruded soy protein for lean tissue growth in early-weaned pigs
BR0312305A (pt) Sistema contendo vitaminas para estabilizar a resposta imune externa e interna de animais
NO20014415L (no) Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
BR0308995A (pt) Método de melhorar a absorção de vitamina e por um animal de estimação
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
BR0207663A (pt) Uso de inibidores de egfr naturais para prevenir os efeitos colaterais devido à terapia com retinóides, sabões e outros estìmulos que ativam o receptor do fator de crescimento epidérmico
BR0313492A (pt) Formulação de anticorpos humanos para tratar distúrbios associados ao tnf-alfa
PT614616E (pt) Composicao para o tratamento de pacientes com doenca hepatica
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0116398A (pt) gel aquoso adequado para ser ingerido por um gato ou por um cão, dieta que atende ao requerimento nutricional de um gato ou um cão, método para pelo menos ajudar na prevenção de distúrbio do trato urinário inferior em um gato ou um cão, método para tratar distúrbios do trato urinário inferior em um gato ou um cão, e, método para ajudar na provisão de um consumo de água total aumentado para um gato ou um cão necessitando do mesmo
BR0008403A (pt) Formulação farmacêutica para administração oral
BR0211344A (pt) Ração animal com baixa concentração de pufa
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BRPI0412332A (pt) método para aumentar nìveis de antioxidante no sangue em um felino, e, composição para dieta adequada para alimentar animais de companhia jovens
EP0626176A3 (en) Food for humans during radiation and / or chemotherapy.
NO20051281L (no) Sammensetning for anrikning av dyrefôr
DK100487A (da) Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
BR9807917A (pt) Método para estimular o sistema imunológico de um animal a prevenir, tratar ou eliminar uma doença parasìtica ou protozoária
DK0414078T3 (da) Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater
BRPI0417093A (pt) composição para consumo animal, método para aumentar a palatabilidade de uma composição de ração, método para aumentar a ingestão de uma ração por um animal, processo para a preparação de uma composição para consumo animal, e, refeição e brinquedo para animal
BR0008774A (pt) Processos para conservar a massa muscular esqueletal de um cão geriátrico, para melhorar a composição do corpo de um cão geriátrico e para reduzir a gordura do corpo de um cão geriátrico
DE69409237D1 (de) Orale, pharmazeutische zusammensetzungen das ein protein oder peptide, eine antikoerper und polymerkugeln enthalten
BR0308576A (pt) Compostos: composições farmacêuticas para administração em um mamìfero e métodos para inibir a enzima citocroma p450rai em um mamìfero

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/899 (2006.01), A23K 20/10 (2016.01), A23K